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The Commission is leading EU Mem-
ber States’ coordination efforts to ex-
change information on surveillance, 
case definition and measures taken 
by EU countries to respond to this 
A(HN) flu virus. The situation is 
changing rapidly and the European 
Centre for Disease Prevention and 
Control is monitoring the situations 
on a continuous basis.
Following human cases of the 
A(HN) flu virus notified to WHO 
by a number of countries, European 
Commission’s Directorate-General 
for Health and Consumers is leading 
the EU coordination under the frame-
work of the Communicable disease 
decision 29/98 through the Com-
munity Early Warning and Response 
System (EWRS), under which EU 
Member States are required to notify 
measures they intend to take as well 
as any confirmed cases.
Health Commissioner Androulla 
Vassiliou called for an extraordinary 
Health Ministers’ meeting which took 
place in Luxembourg on 30 April. The 
meeting discussed further common 
approaches to tackling the A(HN) 
flu virus, including countermeasures 
such as anti-virals and vaccines. The 
Commission holds frequent audio 
meetings with the EU’s Health Secu-
rity Committee and national contact 
points of the Early Warning Rapid 
Alert System (EWRS) with the aim of 
adopting a common guidance docu-
ment on managing the virus. This in-
cludes e.g. information on the case 
definition, advice to travellers and 
management of cases.
The Commission raised its level of 
alert to red on 27 April by launch-
ing its Health Emergency Operat-
ing Facility (HEOF). WHO declared 
level 5 on 29 April. Daily informa-
tion exchange with the MS contact 
points continues. In addition, there 
are regular audio meetings with the 
members of the Global Health Secu-
rity Initiative (G7 countries, Mexico, 
WHO and European Commission). 
Commissioner Vassiliou briefed EU 
foreign ministers on 26 April and 
discussed a common EU approach at 
the extraordinary Health Council.
Commissioner Vassiliou met on 29 
April with pharmaceutical industry 
representatives, in particular with 
the European Vaccine Manufactur-
ers, to address key questions on 
vaccines and antivirals against the 
A(HN) flu virus. The European 
Commission will continue to work 
with the industry, which is commit-
ted to contributing to the efforts in 
the face of the virus.
Regular updates on the situation can be found on:
http://ec.europa.eu/health/ph_threats/com/Influ-
enza/novelflu_en.htm
and
http://ecdc.europa.eu/
2European Parliament likely to build a 
“Europe for Patients”
On 23 April the European Parliament 
voted on three important health policy 
initiatives: patients’ rights in cross border 
healthcare, improving patient safety and 
EU strategy on rare diseases. These ac-
tions mark an important step forward in 
providing patients with better opportu-
nities and access to healthcare in Europe.
The European Parliament also highlight-
ed in all three health votes the need for 
enhanced cooperation between all EU 
Member States, in order to pool knowl-
edge and expertise to maximise health 
benefits for all.
 - Patients Rights in Cross Border Health-
care:
The European Parliament confirmed the 
need for a legislative framework which 
clarifies the rights and conditions under 
which patients seek, and are reimbursed, 
for healthcare in another Member State. 
Many of the amendments sought to 
strengthen patients’ rights through 
greater emphasis on providing public 
information on the quality and safety of 
healthcare.
 - Patient safety and the prevention and 
control of healthcare associated infec-
tions:
The recommendation to improve patient 
safety in Europe and reduce healthcare 
associated infections was adopted by the 
Commission on 5 December 2008. The 
Commission’s proposal aims to help EU 
Member States in one of the biggest chal-
lenges that the EU health systems are fac-
ing – unintended harm to patients while 
receiving healthcare. It is indeed estimat-
ed that 8%-2% of patients admitted to 
hospitals suffer from such harm.
 - European action on rare diseases:
The Communication and Recommen-
dation on rare diseases, adopted by the 
Commission on  November 2008, 
serves as a prime example of where 
working at EU level adds value. It aims to 
improve the recognition of rare diseases 
and pool expertise, experience and re-
search to maximise the effective use of 
resources to the benefit of all rare disease 
patients.
For further information, please view:
http://ec.europa.eu/health-eu/europe_
for_patients/index_en.htm
In brief RAPEX: rise in the number of 
dangerous products in 2008
Commissioner Meglena Kuneva had 
launched the 2008 RAPEX Annual Re-
port at a media event in Brussels on 
20 April. The Annual Report, which 
is published in English, French, Ger-
man and Chinese, provides infor-
mation on the number, origin and 
type of dangerous products notified 
through the RAPEX system and high-
lights how inspections and enforce-
ment actions carried out by Member 
States are becoming increasingly ef-
fective. Annual RAPEX Report 2008 
shows rise in number of dangerous 
products being detected.
The total number of notifications 
distributed through the RAPEX sys-
tem has risen gradually since 2004 
(when the General Product Safety 
Directive was transposed into the 
national laws by Member States). In 
this fifth year, the number of notifi-
cations has quadrupled from 468 (in 
2004) to 866 (in 2008). In 2008, the 
number of notifications rose by 6% 
compared to 2007. The growth in 
RAPEX notifications, also due to the 
increased capacity of the system, is a 
result of more effective product safe-
ty enforcement by national authori-
ties, greater investment of resources, 
greater awareness amongst busi-
nesses of their obligations, enhanced 
cooperation with third countries and 
network-building actions across the 
Member States coordinated by the 
European Commission.
All EU countries participated in the 
RAPEX system by detecting and 
notifying new dangerous products 
and ensuring appropriate follow-up 
actions to the information received. 
Twelve countries further increased 
their activities in the system and no-
tified more dangerous products than 
in 2007. The countries making most 
notifications were Germany (205 no-
tifications), Spain (63 notifications), 
Slovakia (40 notifications), Greece 
(32 notifications) and Hungary (29 
notifications). Notifications sent by 
these countries represent 50% of all 
notifications on products posing a 
serious risk sent via the system.
Toys (498 notifications), electrical ap-
pliances (69 notifications) and mo-
tor vehicles (60 notifications) alone 
accounted for 53% of all notifications 
on products posing a serious risk in 
2008. These results are in line with 
the RAPEX results from 2007. Textile 
products including clothing (with 
40 notifications) became in 2008 
the fourth most frequently notified 
- via RAPEX - category of product.
In total, 909 notifications on prod-
ucts posing a serious risk sent 
through the RAPEX system in 2008 
concerned products manufactured 
in China. The number of products of 
Chinese origin notified via RAPEX in-
creased in 2008 to 59% from 52% in 
2007. The growing tendency should 
be seen in the context of a number 
of factors, such as: increasing im-
ports of goods to the EU from China, 
focus of enforcement actions taken 
at the national level on products of 
Chinese origin, more effective coop-
eration between the EU and China.
The report also shows that Chinese 
authorities increasingly adopt re-
strictive measures on their market, 
on the basis of the RAPEX informa-
tion provided through the “RAPEX-
CHINA” application (established in 
September 2006).
For further information, please view:
http://ec.europa.eu/consumers/safety/rapex/index_
en.htm
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Airlines move to clean up ticket 
selling websites
New EU results published on 4 May show 
a consistent step change in airline ticket 
selling websites across Europe in terms 
of compliance with consumer protec-
tion rules. The findings feature in a final 
report on an 8 month EU-wide process 
to crackdown on misleading advertis-
ing and unfair practices. As a result of an 
EU enforcement investigation started in 
September 2007 – with 5 EU national 
authorities and Norway - 5 airline web-
sites out of the 37 websites investigated 
have been corrected.
Following an additional “health check” 
process, involving independent mystery 
shopping in March 2009 on 67 major 
airlines, 52 airlines have either demon-
strated to maintain the same standards 
or immediately responded to the Com-
mission’s consultation with undertakings 
to remedy outstanding issues.
This “health check” process checked web-
sites against a comprehensive 4 point 
checklist, which was previously agreed 
with the airline industry. The Commission 
is now working to put in place an industry 
wide agreement to provide a level play-
ing field for airlines across the EU and to 
maintain sites to a high standard.
What will happen next?
• The results of such process have been 
passed to national enforcement authori-
ties, to be followed up where necessary.
• The Commission is working with the air-
line industry to put in place an industry 
wide agreement to uphold standards, 
including independent third party moni-
toring. 
• The Commission will bring forward in 
June 2009, a Communication on enforce-
ment, to strengthen the work of the net-
work of national enforcement authorities 
(CPC network) after its first two years of 
operation.
For further information, please view:
http://ec.europa.eu/consumers/enforce-
ment/sweep/index_en.htm
In brief
EU bans dimethylfumarate (DMF) 
in several consumer products
DMF is not legally available for use 
in the manufacture of goods in the 
EU, since biocidal products contain-
ing DMF are not authorised under 
the Biocides Directive (98/8/EC). 
However, manufacturers outside the 
EU may use these unauthorised bio-
cides and then export their products 
to the EU.
The new Decision adopted will cover 
all Member States and will ensure a 
ban of DMF in all consumers prod-
ucts (maximum limit value: 0. mg/
kg) across the EU. The Decision there-
fore protects EU consumers from the 
risk of DMF in imported products in 
the same way as they are protected 
at home.
On  May a European Commission 
Decision came into force to ensure 
that no consumer product contai-
ning the strongly sensitising DMF is 
placed on the market in the EU. The 
biocide dimethylfumarate (DMF) has 
caused severe allergic reactions be-
cause of its use in imported products 
such as sofas, shoes and soft toys.
Dimethylfumarate (DMF) is used by 
producers as a biocide to kill moulds 
that may cause damages to prod-
ucts such as furniture or shoes dur-
ing storage or transportation in a 
humid climate. Placed in “desiccant” 
sachets inside the furniture or foot-
wear boxes, DMF evaporates and im-
pregnates the product, protecting it 
from moulds. However, it has been 
found to seriously affect consumers 
who were in contact with the prod-
ucts, causing painful dermatitis.
For further information, please view:
http://europa.eu/rapid/pressReleasesAction.
do?reference=IP/09/ 676&format=HTML&aged=0&la
nguage=EN
For further information, please visit:
http://ecvam.jrc.it/
Alternatives to animal testing
validation and evaluation of in-vitro 
toxicity testing methods. Strength-
ened collaboration among the sig-
natories will ensure that alternative 
methods are reproducible, based 
on sound science and able to accu-
rately identify health hazards. This, in 
turn, should facilitate test methods 
that are widely accepted by regula-
tory bodies in the EU, Japan, the US, 
Canada and internationally by the 
OECD.
It is expected that, as a result of the 
agreement, testing methods that 
undergo scientific validation will 
be more credible and more rapidly 
applied by the testing community. 
The organisations will also work to-
gether to develop harmonised rec-
ommendations on regulatory issues 
and develop peer-review processing 
mechanisms.
Global efforts to promote alternati-
ves to testing on animals received 
a significant boost through the si-
gning of a cooperation agreement 
by international bodies, including 
the European Commission’s Joint 
Research Centre (JRC), tasked with 
the validation of alternative test 
methods.
A cooperation agreement that 
should give new impetus to the 
worldwide availability of scientifical-
ly proven alternatives to animal test 
methods has been signed by the 
European Centre for the Validation 
of Alternative Methods (ECVAM), 
which is part of the Commission’s 
Joint Research Centre, together with 
its equivalent in the US and in Japan 
and Canada’s Environmental Health 
Science and Research Bureau. 
The agreement establishes en-
hanced international cooperation 
and coordination on the scientific 
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European Child Safety Cards 2009
Commissioner for Health Vassiliou 
and Commissioner for Consumer Af-
fairs Kuneva launch European Child 
Safety Report Cards 2009, recently 
published by the European Child Sa-
fety Alliance for 24 European coun-
tries. The report cards score coun-
tries on the degree to which they 
have adopted, implemented and 
enforced proven child-injury strate-
gies and good practices.
Each year about 0,000 children die 
in the European Union due to unin-
tentional injuries. That is equivalent 
to losing an entire school classroom 
of children, more than 25 students, 
every day of the year. Yet it has been 
estimated by researchers that if all 
strategies known to be effective 
were uniformly implemented, ap-
proximately 90% of these injuries 
could be prevented.
On 6 May the European Child Safety 
Alliance published child safety re-
port cards for 24 European countries 
and a European summary report. 
The report cards give the participat-
ing countries a clear view of per-
formance gaps and actions required 
to reduce injury-related death and 
disability among Europe’s most vul-
nerable citizens – children.
The report cards, co-funded by 
the European Commission’s Public 
Health Programme,  score countries 
on their level of adoption, imple-
mentation and enforcement of over 
00 proven, effective child injury 
prevention strategies – good prac-
tices known to save children’s lives. 
The good practice policies relate 
to road traffic accidents, drowning, 
falls, poisoning, burns, choking and 
support data infrastructure and pro-
fessional capacity necessary to com-
bat child injury.
There is great variability between 
the best performing and poorer 
performing countries, with injury 
death rating up to 4 times higher in 
the countries with the poorest per-
formance. Among the 24 countries 
participating in these report card as-
sessments, the highest unintention-
al child injury death rates are found 
in Latvia, Lithuania and Estonia and 
the lowest are found in the Nether-
lands, the United Kingdom, Ireland 
and Sweden.
As concerns the uptake of the proven 
good practices, the best child safety 
performance scores were achieved 
in Iceland, the Netherlands and 
Sweden, while the worst perform-
ing countries seem to be Greece and 
Portugal.
These results suggest that the proc-
ess of developing and implement-
ing child safety action plans does 
lead to increased attention and 
commitment to the child injury issue 
and steps towards uptake of proven 
good practices. 
Arlene McCarthy, European Socialist 
Party MEP and Chair of the Internal 
Market and Consumer Protection 
Committee, also participated to the 
launch, advocating support for EU 
policy measures that address child 
safety priorities and are based on 
evidenced good practices.
“In this time of economic downturn, 
it will be critical that safety issues 
and our children are not compro-
mised”, the two Commissioners de-
clared. “In 2009 and beyond it will 
be a priority to ensure that Member 
States enhance their commitment 
to child safety, with allocation of suf-
ficient resources for uptake and en-
forcement of good safety practices 
and policies”.
For further information, please view:
http://www.childsafetyeurope.org
Call for expression of interest: 
Stakeholder Dialogue Group
DG Health & Consumers is looking to 
renew up to 0 of the members of its 
Stakeholder Dialogue Group. For the 
purpose, it launched a call for expres-
sion of interest on 4 May 2009. Interest-
ed applicants should submit a one-page 
letter explaining why they consider their 
professional background relevant to the 
activity of the Stakeholder Dialogue 
Group and a CV of maximum 2 pages by 
6 June 2009 to:
SANCO-stakeholders@ec.europa.eu
You can access the full text of the call 
at:
http://ec.europa.eu/dgs/health_con-
sumer/index_en.htm
World Veterinary Day and the “One 
Health” Roadshow
The World Veterinary Day was intro-
duced by the World Veterinary Asso-
ciation in 2000, to celebrate the crucial 
contribution of veterinarians to society, 
usually with an accompanying theme. 
This year the theme has been “Veterinar-
ians and Livestock Farmers: A Winning 
Partnership”.
In Brussels, the European Commission’s 
Directorate-General for Health and Con-
sumers organised an event on Friday 24 
April. The Commission’s “One Health” 
roadshow was present to promote the 
work of EU veterinarians to the general 
public and to explain how animal health 
is linked to human health.
The “One Health” roadshow is a custom-
ised vehicle which has been travelling 
around the EU since November 2008.
This initiative was launched in the frame 
of the 2008 edition of the EU Veterinary 
Week. The next edition of such event 
will take place on 28 September to 4 Oc-
tober 2009.
For more information, please visit:
http://www.one-health.eu
In brief
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